A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26692/fullpdf
Reference27 articles.
1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010
2. ESMO Guidelines Working Group. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment;Van Cutsem;Ann Oncol,2010
3. Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons;Anderson;Cancer,1992
4. A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma;Machover;Cancer,1997
5. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer;Giacchetti;J Clin Oncol,2000
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment;International Journal of Molecular Sciences;2024-03-09
2. An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases;International Journal of Molecular Sciences;2023-12-18
3. Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy;Nano Today;2023-02
4. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis;Diagnostics;2022-11-25
5. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer;Frontiers in Pharmacology;2021-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3